Increased Risk of Hospitalisation Associated with Infection with SARS-CoV-2 Lineage B.1.1.7 in Denmark
Peter Bager(Statens Serum Institut), Tyra Grove Krause(Statens Serum Institut), Jannik Fonager(Statens Serum Institut), Kåre Mølbak(Statens Serum Institut), Marianne Voldstedlund(Statens Serum Institut), Rebecca Legarth(Statens Serum Institut), Camilla Holten Møller(Statens Serum Institut), Thomas Yssing Michaelsen(Aalborg University Hospital), Mads Albertsen(Aalborg University), Robert Skov(Statens Serum Institut), Anders Fomsgaard(Statens Serum Institut), Sophie Gubbels(Statens Serum Institut), Steen Ethelberg(Statens Serum Institut), Mia Sara Fischer Button(Statens Serum Institut), Jan Wohlfahrt(Statens Serum Institut)
Cited by 47
Related Papers
Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study
|The Lancet Infectious Diseases|2011|929
German Outbreak of<i>Escherichia coli</i>O104:H4 Associated with Sprouts
|New England Journal of Medicine|2011|718
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data
|The Lancet Respiratory Medicine|2014|648
Rapid detection, differentiation and typing of methicillin-resistant Staphylococcus aureus harbouring either mecA or the new mecA homologue mecALGA251
|Clinical Microbiology and Infection|2011|429